Research

Conditions:

Funding types:

Region:

Priority:

Eye category:

Status

All

Active

Completed

Starting soon

Galectin-3 as a determinant of T cell-driven pathology: targeting galectin-3 to restore tissue integrity in uveitis and arthritis-associated uveitis.

Active

October 2024 - October 2027
Developing mitochondrial-targeted therapies for the multisystem management of diabetic eye disease

Active

September 2024 - September 2027
Tear proteomics and electrophysiology in infants at risk of retinopathy of prematurity

Active

September 2024 - August 2027
Corneal Nanoinjection: a nanoneedle platform for gene editing in inherited corneal endothelial disorders

Active

June 2024 - November 2024
Characterisation of the smooth zone of retinal autofluorescence in the macula of choroideremia patients as a biomarker for use as an approvable endpoint in a pivotal gene therapy trial

Active

June 2024 - May 2027
Developing an avascular zone in the Stargardt mouse retina

Active

April 2024 - March 2025
Evaluation of the efficacy of blocking light below 460 nm in protection from light-induced retinal injury in mouse models of Stargardt's disease

Active

May 2024 - May 2025
Innovative DARC Technology: A Window into Corneal Endothelial Cell Health

Active

June 2024 - May 2025
Adult gonococcal conjunctivitis in the United Kingdom; a prospective study on incidence, presentation, microbiology, management and outcomes.

Active

January 2024 - January 2025